Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

11.25
Delayed Data
As of Dec 09
 -0.05 / -0.44%
Today’s Change
6.00
Today|||52-Week Range
12.98
+7.55%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close11.30
Today’s open11.35
Day’s range11.15 - 11.65
Volume216,017
Average volume (3 months)338,253
Market cap$455.8M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)+78.18%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book6.49

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc-0.20-1.50%
NOVNNovan Inc-0.15-0.53%
MYOKMyoKardia Inc-0.30-2.07%
CTMXCytomX Therapeutics ...+0.07+0.57%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs